Skip to content
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Published Manuscript
Ab Interno Minimally Invasive Glaucoma Surgery Combined with Cataract Surgery and Cataract Surgery Alone: IRIS®️ Registry Study
April 7, 2024
Read More...
Comparison of Methods of Clinical Trial Emulation Utilizing Data from the Comparison of AMD Treatment Trial (CATT) and the IRISⓇ Registry
April 3, 2024
Read More...
Multi-registry analysis of patients with multiple sclerosis and neuromyelitis optica to improve capture of demographic data and compare visual outcomes
February 11, 2024
Read More...
Vitreoretinal Specialist Use of Ancillary Testing: An IRIS
®️
Registry Analysis
October 20, 2023
Read More...
Vitreoretinal Specialist Use of Ancillary Testing: An IRIS® Registry Analysis
October 17, 2023
Read More...
Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in nAMD: Up to 6-Year Analysis of the AAO IRIS® Registry
October 10, 2023
Read More...
Progression of Geographic Atrophy: Retrospective Analysis of Patients from the IRIS®️ Registry (Intelligent Research in Sight)
April 2, 2023
Read More...
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS Registry
April 1, 2023
Read More...
Identifying the Mechanisms of Missingness for Unspecified Diabetic Retinopathy Disease Severity in the Electronic Health Record: An IRIS® Registry Analysis
March 16, 2023
Read More...
Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry
January 1, 2023
Read More...
« Previous
1
2
3
4
…
6
Next »